GenixCure

뉴스&공지

뉴스&공지

뉴스

Signed Joint R&D Agreement with ToolGen

2022-12-20

▲ Kim Young-ho, CEO of ToolGen (left), and Moon Hong-sung, CEO of GENIXCURE

View the original article

이전글: Strategic Alliance with MedySapiens for Rare Disease Programs

다음글: GXC-301 presented by Christopher Lim at '2023 Lafora Disease Science Symposium...